Journal Information
Vol. 41. Issue 2.
Pages 93-98 (February 2005)
Share
Share
Download PDF
More article options
Vol. 41. Issue 2.
Pages 93-98 (February 2005)
Review Article
Full text access
Pulmonary Manifestations of Inflammatory Bowel Disease
Visits
6978
M.C. Vennera
Corresponding author
mvennera@hotmail.com

Correspondence: Dra. M.C. Vennera. Servei de Pneumologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España
, C. Picado
Servei de Pneumologia, Hospital Clínic, Barcelona, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
EH Rubin.
The lung as a mirror of systemic disease, Charles C. Thomas, (1956),
[2]
SC Kraft, RH Earle, M Rossler, JR Estarly.
Unexplained bronchopulmonary disease with inflammatory bowel disease.
Arch Intern Med., 136 (1976), pp. 454-459
[3]
F Veloso, J Carvalho, F Magro.
Immune-related manifestations of inflammatory bowel disease: a prospective study of 792 patients.
J Clin Gatroenterol., 23 (1996), pp. 29-34
[4]
GB Rankin, HD Watts, CJ Melnyk, et al.
National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.
Gastroenterology, 77 (1979), pp. 914-920
[5]
AJ Greenstein, HD Janowitz, DB Sachar.
The extraintestinal complications of Crohn's disease and ulcerative colitis.
Medicine (Baltimore), 55 (1976), pp. 401-412
[6]
J Hinojosa, J Primo, S Lledó, A López, JV Roig, J Fernández.
Incidencia de enfermedad inflamatoria intestinal en Sagunto.
Rev Esp Enf Ap Dig., 78 (1990), pp. 283-287
[7]
R Solá la Moglia, AM García-Pugués, J Monés Xiol, C Badosa Gallart, J Badosa Gallart, F Casellas, et al.
Enfermedad inflamatoria crónica intestinal en Cataluña (Barcelona y Gerona).
Rev Esp Enf Ap Digest, 81 (1992), pp. 7-14
[8]
Y Ogura, DK Bonen, N Inohara, et al.
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Nature, 411 (2001), pp. 603-606
[9]
I Storch, D Sachar, S Katz.
Pulmonary manifestations of inflammatory bowel disease.
Inflamm Bowel Dis., 9 (2003), pp. 104-115
[10]
R Mahadeva, G Walsh, CDR Flower, JM Shneerson.
Clinical and radiological characteristics of lung disease in inflammatory bowel disease.
Eur Respir J., 15 (2000), pp. 41-48
[11]
PH Camus, TV Colby.
The lung in inflammatory bowel disease.
Eur Respir J., 15 (2000), pp. 5-10
[12]
JH Kelly, WW Montgomery, ML Goodman, TJ Mulvaney.
Upper airway obstruction associated with regional enteritis.
Ann Otol Rhinol Laryngol., 88 (1979), pp. 95-99
[13]
P Camus, F Piard, T Ashcroft, AA Gal, TV Colby.
The lung in inflammatory bowel disease.
Medicine (Baltimore), 72 (1993), pp. 151-183
[14]
A Karasalihoglu, K Kutlu, T Yilmaz.
Obstruction laringe-trachéale en cas de colitis ulcéreuse.
Rev Laryngol., 109 (1988), pp. 468-471
[15]
P Wilcox, R Millar, G Millar, J Heath, B Nelems, N Muller, et al.
Airway involvement in ulcerative colitis.
Chest, 92 (1987), pp. 18-22
[16]
M Cohen, S Sahn.
Bronchiectasis in systemic diseases.
Chest, 116 (1999), pp. 1063-1074
[17]
T Higenbottam, GM Cochrane, TJH Clark, et al.
Bronchial disease in ulcerative colitis.
Thorax, 35 (1980), pp. 581-585
[18]
RJA Butland, P Cole, KM Citron, et al.
Chronic bronchial suppuration and inflammatory bowel disease.
Q J Med., 50 (1981), pp. 63-75
[19]
KW Moles, G Barghese, JR Hayes.
Pulmonary involvement in ulcerative colitis.
Br J Dis Chest, 82 (1988), pp. 79-83
[20]
H Rickli, C Fretz, M Hoffman, A Walser, A Knoblauch.
Severe inflammatory upper airway stenosis in ulcerative colitis.
Eur Respir J., 7 (1994), pp. 1899-1902
[21]
SJ Desai, GN Gephardt, JK Stoller.
Diffuse panbronchiolitis preceding ulcerative colitis.
Chest, 45 (1989), pp. 1342-1344
[22]
M Iwata, A Sato, TV Colby.
Diffuse panbronchiolitis.
Diseases of the bronchioles, pp. 153-179
[23]
W Schulte, A Szrepka, PC Bauer, J Guzmán, U Costabel.
Diffuse panbronchiolitis.
DTSCH Med Wochenschr., 124 (1999), pp. 584-588
[24]
CR Swinburn, GJ Jackson, T Ascroft, GN Morrit, PA Corris.
Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis.
Thorax, 43 (1988), pp. 735-736
[25]
Z Fireman, A Osipov, S Kivity, Y Kopelman, A Sternberg, E Lazarov, et al.
The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease.
Am J Gastroenterol., 95 (2000), pp. 730-734
[26]
P Bonniere, B Wallaert, A Cortot, X Marchandise, Y Riou, AB Tonnel, et al.
Latent pulmonary involvement in Crohn's disease: biological, functional, broncoalveolar lavage and scintigraphic studies.
Gut, 27 (1986), pp. 919-925
[27]
GH Koek, GM Verleden, P Evenepoel, P Rutgeerts.
Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?.
Respir Med., 96 (2002), pp. 530-535
[28]
BB Ceyhan, S Karakurt, H Cevik, M Sungur.
Bronchial hyperreactivity and allergic status in inflammatory bowel disease.
Respiration, 70 (2003), pp. 60-66
[29]
K Herrlinger, M Noftz, K Dalhoff, D Ludwig, E Stange, K Fellermann.
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
Am J Gastroenterol., 97 (2002), pp. 377-381
[30]
D Podolsky.
Inflammatory bowel disease.
N Engl J Med., 347 (2002), pp. 417-429
[31]
J Cosnes, L Beaugerie, F Carbornnel, JP Gendre.
Smoking cessation and the course of Crohn's disease: an intervention study.
Gastroenterology, 120 (2001), pp. 1093-1099
[32]
E Lindberg, C Tysk, K Andersson, G Jarnerot.
Smoking and inflammatory bowel disease: a case control study.
Gut, 29 (1988), pp. 352-357
[33]
RE Andersson, G Olaison, C Tysk, A Ekbom.
Appendectomy and protection against ulcerative colitis.
N Engl J Med., 334 (2001), pp. 808-814
[34]
JM Evans, AD McMahon, FE Murray, DG McDevitt, TM Mac Donald.
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
Gut, 40 (1997), pp. 619-622
[35]
HC Rath, M Schultz, R Freitag, et al.
Different subsets of enteric induce and perpetuate experimental colitis in rats and mice.
Infect Immun., 69 (2001), pp. 2277-2285
[36]
CO Elson.
Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis.
Mucosal immunology, 2nd ed., pp. 1007-1024
[37]
IJ Fuss, M Neurath, M Boirivant, et al.
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
J Immunol., 157 (1996), pp. 1261-1270
[38]
A Swidsinski, A Ladhoff, A Pernthaler, et al.
Mucosal flora in inflammatory bowel disease.
Gastroenterology, 122 (2002), pp. 44-54
[39]
C Fiocchi.
Inflammatory bowel disease: etiology and pathogenesis.
Gastroenterology, 115 (1998), pp. 182-205
[40]
JB Kirsner.
Ulcerative colitis 1970: recent developments.
Scand J Gastroenterol., 6 (1970), pp. 63-91
[41]
W Kinnear, T Higenbottam.
Pulmonary manifestations of inflammatory bowel disease.
Inter Med Spec., 4 (1983), pp. 104-111
[42]
JB Kirsner, RG Shorter.
Recent developments in “non-specific” inflammatory bowel disease.
N Engl J Med., 306 (1982), pp. 775-785
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?